24.11.2020
Erster gesetzlicher Schritt ermöglicht Mehrpersonal in Pflegeheimen

Erster gesetzlicher Schritt ermöglicht Mehrpersonal in Pflegeheimen

Heinz Rothgang als Sachverständiger bei Anhörung zum Gesetz zur Verbesserung der Gesundheitsversorgung und Pflege

Am 16.11.20 wurde im Gesundheitsausschuss des Bundestages in einer öffentlichen Anhörung über den aktuellen Entwurf für ein Gesetz zur Verbesserung der Gesundheitsversorgung und Pflege beraten. Neben einigen Regelungen, die sich mit Bewältigung der Corona-Pandemie und der Versorgung in speziellen medizinischen Bereichen beschäftigen, wird pflegepolitisch die Verbesserung der Personalausstattung in Pflegeheimen umgesetzt Read more ...

03.11.2020
First scientific study on Fridays for Future

First scientific study on Fridays for Future

Fridays for Future – Die Jugend gegen den Klimawandel. Konturen der weltweiten Protestbewegung

Fridays for Future was successfull where environmental NGOs and climate protests in the 20 years before failed. They have succeeded to alter the issue of climate change from a relatively abstract topic that is negotiated at international conferences to one that mobilizes tens of thousands of people to protest on the streets. In the six months before the Corona pandemic, according to opinion polls, climate change had become the top most important issue in Germany. Read more ...

16.09.2020
New drugs in the Innovation Report 2020: Do they deliver what they promise?

New drugs in the Innovation Report 2020: Do they deliver what they promise?

The Innovation Report 2020 evaluates drugs that entered the German market in 2017

The Innovation Report 2020 evaluates 30 drugs for outpatient care and one vaccine that were launched on the German market in 2017. In the eighth edition of the Innovation Report, which is edited by Professor Dr. Gerd Glaeske, the prices and the relevant publications on the respective drugs are reviewed and summarized at this point in time, and the products are evaluated using a traffic light system. The supply reality is represented by the secondary data of the Techniker Krankenkasse, which shows the actual use of the drugs and the costs in the field. Read more ...